Tamoxifen modulation of cisplatin cytoto
โ
Edward F. McClay; Kathleen D. Albright; Jeffrey A. Jones; Randolph D. Christen;
๐
Article
๐
1993
๐
John Wiley and Sons
๐
French
โ 479 KB
Recent clinical trials have indicated that addition of tamoxifen (TAM) to a combination of cisplatin (DDP), carmustine and dacarbazine markedly increases the overall objective response rate of patients with metastatic malignant melanoma. Previous studies have determined that there is remarkable syne